Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Studies in health technology and informatics ; h5-index 23.0

Alzheimer's Disease (AD) is a neurodegenerative disease that causes complications with thinking capability, memory and behavior. AD is a major public health problem among the elderly in developed and developing countries. With the growth of AD around the world, there is a need to further expand our understanding of the roles different clinical measurements can have in the diagnosis of AD. In this work, we propose a machine learning-based technique to distinguish control subjects with no cognitive impairments, AD subjects, and subjects with mild cognitive impairment (MCI), often seen as precursors of AD. We utilized several machine learning (ML) techniques and found that Gradient Boosting Decision Trees achieved the highest performance above 84% classification accuracy. Also, we determined the importance of the features (clinical biomarkers) contributing to the proposed multi-class classification system. Further investigation on the biomarkers will pave the way to introduce better treatment plan for AD patients.

Refaee Mahmoud Ahmed, Ali Amal Awadalla Mohamed, Elfadl Asma Hamid, Abujazar Maha F A, Islam Mohammad Tariqul, Kawsar Ferdaus Ahmed, Househ Mowafa, Shah Zubair, Alam Tanvir

2020-Jun-26

ADNI, Alzheimer’s Disease, Dementia, Mild Cognitive Impairment